Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-02-05

Clinical Trial Update: A Study of Lurasidone HCl in Subjects With Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 trial assessing lurasidone hydrochloride in adults with schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lurasidone hydrochloride (Lurasidone hydrochloride)

Snippet

Sponsor: Standard Chem. & Pharm. Co., Ltd. | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED